SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
242.00    7.00 (2.98%)
Bid:
234.00
Ask:
242.00
Spread: 8.00 (3.419%)
Market Cap: £77.41m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

Director/PDMR Shareholding

20 Dec 2023 15:53

RNS Number : 5146X
Braemar PLC
20 December 2023
 

 

20 December 2023

BRAEMAR PLC

("Braemar" or the "Company")

 

Director/PDMR Shareholding

Braemar Plc (LSE: BMS), a leading international shipbroker and provider of expert investment, chartering, and risk management advice to the shipping and energy markets announces the following Director/PDMR share dealing transactions:

On 18 December 2023, the trustee of the Braemar Employee Share Ownership Plan approved the release of ordinary shares of 10p each in the Company ("Ordinary Shares") to certain employees of Braemar following the vesting of share awards granted under the Company's Deferred Bonus Plan ("DBP") and the exercise of linked options granted under the Company Share Option Plan ("CSOP"), including three persons discharging managerial responsibilities ("PDMRs") of the Company, as follows:

Director/PDMR

Number of ordinary shares released

James Gundy - Group Chief Executive Officer

397,073

Tris Simmonds - Group Chief Operating Officer

34,511

Alistair Borthwick - Group Finance Director

44,043

 

The CSOP awards carried an exercise price of £1.22 per share. Following the DBP vesting and CSOP exercises, James Gundy sold 397,073 Ordinary Shares, Tris Simmonds sold 34,511 Ordinary Shares, Alistair Borthwick sold 20,486 Ordinary Shares at a price of £2.764811. On 18 December 2023, Tris Simmonds also sold 28,367 shares at a price of £2.764811.

 

Following the above transactions, the total holding of Ordinary Shares of each of James Gundy, Tris Simmonds and Alistair Borthwick (including those of persons closely associated with them) will be as follows:

 

PDMR

Total number of Ordinary Shares

James Gundy - Group Chief Executive Officer

772,165

Tris Simmonds - Group Chief Operating Officer

320,080

Alistair Borthwick - Group Finance Director

56,448

 

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information, contact:

Braemar Plc

James Gundy, Group Chief Executive Officer

Tel +44 (0) 20 3142 4100

Grant Foley, Group Chief Financial Officer

Rebecca-Joy Wekwete, Company Secretary

Buchanan

Charles Ryland / Stephanie Whitmore / Jamie Hooper

Tel +44 (0) 20 7466 5000

Investec Bank plc

Gary Clarence / Harry Hargreaves / Alice King

Tel +44 (0) 20 7597 5970

Cavendish Securities PLC

Ben Jeynes / Matt Lewis (Corporate Finance)

Leif Powis /Dale Bellis/ Charlie Combe (Sales & ECM)

 

Tel +44 (0) 20 7220 0500

 

 

Details of the person discharging managerial responsibilities / person closely associated

Name

James Gundy

Reason for the notification

Position/status

Group Chief Executive Officer

Initial notification /Amendment

Initial

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

Name

Braemar Plc

LEI

213800EV6IKTTHJ83C19

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Ordinary shares of 10p each 

Identification code

GB0000600931

Nature of the transaction 

Sale of shares acquired from the vesting of share awards granted under the Braemar Plc Deferred Bonus Plan

Price(s) and volume(s)

Price:  £2.764811

Volume: 397,073

Aggregated information

 - Aggregated volume

- Price

 

397,073

£1,095,485.14

Date of the transaction

18 December 2023

Place of the transaction 

London Stock Exchange (XLON)

 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Ordinary shares of 10p each 

Identification code

GB0000600931

Nature of the transaction 

Exercise of options granted under the Company Share Option Plan with an exercise price of 122p per share.

Price(s) and volume(s)

Price: 122p

Volume: 24,650

Aggregated information

 - Aggregated volume

- Price

 

24,650

£30,073.00

Date of the transaction

18 December 2023

Place of the transaction 

London Stock Exchange (XLON)

 

Details of the person discharging managerial responsibilities / person closely associated

Name

Tris Simmonds

Reason for the notification

Position/status

Group Chief Operations Officer

Initial notification /Amendment

Initial

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

Name

Braemar Plc

LEI

213800EV6IKTTHJ83C19

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Ordinary shares of 10p each 

Identification code

GB0000600931

Nature of the transaction 

Sale of shares acquired from the vesting of share awards granted under the Braemar Plc Deferred Bonus Plan

Price(s) and volume(s)

 

Price: £2.764811

Volume: 34,511

Aggregated information

 - Aggregated volume

- Price

 

34,511

£95,081.43

Date of the transaction

18 December 2023

Place of the transaction 

London Stock Exchange (XLON)

 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Ordinary shares of 10p each 

Identification code

GB0000600931

Nature of the transaction 

Sale of shares

Price(s) and volume(s)

Price: £2.764811

Volume: 28,367

Aggregated information

 - Aggregated volume

- Price

 

28,367

£78,429.39

Date of the transaction

18 December 2023

Place of the transaction 

London Stock Exchange (XLON)

 

Details of the person discharging managerial responsibilities / person closely associated

Name

Alistair Borthwick 

Reason for the notification

Position/status

Group Finance Director

Initial notification /Amendment

Initial

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

Name

Braemar Plc

LEI

213800EV6IKTTHJ83C19

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Ordinary shares of 10p each 

Identification code

GB0000600931

Nature of the transaction 

Sale of shares acquired from the vesting of share awards granted under the Braemar Plc Deferred Bonus Plan

Price(s) and volume(s)

Price: £2.764811

Volume: 20,486

Aggregated information

 - Aggregated volume

- Price

 

20,486

£56,440.68

Date of the transaction

18 December 2023

Place of the transaction 

London Stock Exchange (XLON)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Ordinary shares of 10p each 

Identification code

GB0000600931

Nature of the transaction 

Exercise of options granted under the Company Share Option Plan with an exercise price of 122p per share.

Price(s) and volume(s)

Price: 122p

Volume: 6,705

Aggregated information

 - Aggregated volume

- Price

 

6,705

£8,180.10

Date of the transaction

18 December 2023

Place of the transaction 

London Stock Exchange (XLON)

 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZMZZKGMGFZM
Date   Source Headline
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20252:47 pmRNSGrant of Share Incentives to PDMRs
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20254:15 pmRNSDirector/PDMR Shareholding
2nd Jul 20254:07 pmRNSResults of 2025 Annual General Meeting
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:01 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 202511:11 amRNSInvestigation Update
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20251:42 pmRNSNotice of 2025 Annual General Meeting
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20254:50 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:01 amRNSCommencement of Share Buyback Programme
29th May 20257:00 amRNSFY25 Final Results
20th May 202510:00 amRNS-RInvestor Presentation at Mello London
15th May 20257:00 amRNSNotice of FY25 Results
2nd May 202512:14 pmRNSTotal Voting Rights
1st Apr 20253:43 pmRNSTotal Voting Rights
24th Mar 20257:00 amRNSFY25 Trading Update
7th Mar 20257:00 amRNSDirectorate Change
28th Feb 20259:04 amRNSTotal Voting Rights
31st Jan 20253:14 pmRNSTotal Voting Rights
31st Dec 20247:00 amRNSTotal Voting Rights
17th Dec 202410:23 amRNSHolding(s) in Company
10th Dec 20244:48 pmRNSHolding(s) in Company
10th Dec 20244:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20249:27 amRNSTotal Voting Rights
28th Nov 20244:17 pmRNSPDMR Share Dealing
25th Nov 202411:41 amRNSPDMR Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.